CORAL - Cebranopadol Versus Morphine Prolonged-release in Patients With Chronic Moderate to Severe Pain Related to Cancer
Status:
Terminated
Trial end date:
2015-10-16
Target enrollment:
Participant gender:
Summary
Pain is one of the most common symptoms associated with malignant tumor. The purpose of this
trial is to determine whether cebranopadol is as effective in patients with cancer related
pain as morphine sulfate prolonged release (PR).